This is breast cancer that occurs in men. While it's less common than in women, it's still important to be aware of the signs and get checked if you have concerns.
Every report comes from a Lived member, sent anonymously.
Have you tried Tamoxifen for Male Breast Cancer?
Male breast cancer is cancer that starts in the small amount of breast tissue men have behind and around the nipple. It is rare: fewer than 1 in 100 breast cancers in the United States occur in men. It can happen at any age, but the average age at diagnosis is between 60 and 70. The most common sign is a lump, usually firm and painless, under or near the nipple. Other changes include a nipple that turns inward or points in a new direction, clear or bloody discharge from the nipple, dimpled, red, scaly or broken skin over the breast, and a lump or swelling in the armpit or near the collarbone. Most male breast cancers start in the milk ducts and are invasive, meaning they have grown into surrounding tissue and can spread to lymph nodes and beyond. Because few men expect breast cancer, a lump is often left unchecked for a while, and men are more likely than women to be diagnosed at a later stage.
Older age is the main risk factor. Most men who develop breast cancer have no clear cause, and most men with a risk factor never develop it. Inherited gene changes play a larger role than many people realize. The BRCA1 and BRCA2 genes normally help repair damaged DNA. Men who inherit a harmful BRCA2 variant have about a 7 in 100 lifetime chance of breast cancer, compared with roughly 1 in 755 for men overall. A BRCA1 variant raises the risk less, and harmful variants in a few other genes are also linked to it. Several female relatives with breast cancer can be a sign that one of these variants runs in the family. Hormone balance is the other main thread. Conditions that raise estrogen relative to testosterone increase risk: Klinefelter syndrome (a genetic condition in which a man has an extra X chromosome), cirrhosis of the liver, testicular problems such as an undescended testicle, inflamed testicles or removal of the testicles, and obesity. Estrogen-based treatments, including some used for prostate cancer and high-dose estrogen in gender-affirming care, may also raise risk. Previous radiation to the chest, for example for lymphoma, and heavy drinking are other recognized contributors.
Assessment starts with an exam of the breasts and armpits and questions about symptoms and family history. The main look-alike is gynecomastia, a harmless growth of breast tissue that is far more common than cancer and is often linked to hormone shifts, excess weight or certain medicines. Gynecomastia also forms a button-like growth under the nipple, so touch alone cannot tell the two apart. Imaging usually means a mammogram, an ultrasound or both. In men younger than 25, when cancer is very unlikely, ultrasound usually comes first. If anything looks suspicious, a core needle biopsy removes small samples of tissue so a pathologist can confirm whether cancer is present. If it is cancer, the tissue is tested for hormone receptors (proteins that let estrogen and progesterone fuel the cancer's growth) and for HER2, a protein that drives cell growth in some cancers. Nearly all male breast cancers are hormone receptor positive, which shapes treatment. CT, PET or bone scans may check for spread, and the cancer is staged (graded by its size, lymph node involvement and spread) the same way as in women. Genetic counseling and testing for inherited gene changes should be offered to every man diagnosed, because a result such as a BRCA2 variant can affect treatment, raises the risk of other cancers such as prostate and pancreatic cancer, and matters for brothers, sisters and children. Routine screening mammograms are not usually recommended for men, even those at higher risk. Instead, men at higher risk may be advised to watch for breast changes and have regular clinical breast exams.
Treatment follows the same principles as for women, because there are too few men with breast cancer to run large trials of their own. Most evidence specific to men comes from smaller observational studies, so many choices are carried over from what works in women. Surgery is the main treatment for cancer that has not spread to distant organs. Men usually have a mastectomy (removal of the whole breast) because there is little tissue to spare, although a lumpectomy, which removes only the tumor and a margin of healthy tissue, is possible for some. Lumpectomy is normally followed by radiation, and radiation is sometimes used after mastectomy as well. The surgeon also checks the armpit lymph nodes, often by removing just the first one or few nodes the tumor drains to (a sentinel lymph node biopsy). Removing lymph nodes can cause lasting swelling of the arm, called lymphedema. Because almost all of these cancers are fueled by estrogen, hormone therapy is the backbone of treatment after surgery. Tamoxifen, a daily pill that blocks estrogen from acting on cancer cells, is usually taken for five years, and sometimes for another five when the risk of return stays high. It lowers the chance of the cancer coming back, but its side effects (hot flashes, sexual problems such as difficulty with erections, and fatigue) are bad enough for a significant share of men to cut treatment short, so they are worth raising with the care team early. When tamoxifen cannot be used, an aromatase inhibitor such as anastrozole (Arimidex) or letrozole (Femara), which lowers the estrogen made in body tissues, is given together with a medicine that switches off hormone production by the testicles. An aromatase inhibitor on its own is not recommended for men, and the combination can thin the bones, so bone health is monitored. Chemotherapy may be added when the cancer is larger, has reached lymph nodes or has other high-risk features, and HER2-positive cancers are treated with HER2-targeted drugs such as trastuzumab. For cancer that has spread to distant organs, hormone therapy is usually the first choice unless the disease is moving quickly or threatening organ function. It is often combined with a targeted pill that slows cancer cell division, and chemotherapy and other targeted treatments are used on the same principles as in women. Metastatic breast cancer is not usually curable, but treatment aims to control it and protect quality of life, sometimes for years.
Outlook depends mainly on the stage at diagnosis. In US figures, men whose cancer is confined to the breast are, five years after diagnosis, about 98% as likely to be alive as men without breast cancer. That figure is about 85% when the cancer has reached nearby lymph nodes and about 35% when it has spread to distant organs. These are averages from people diagnosed in past years and cannot predict one person's course. Men as a group fare somewhat worse than women, partly because they tend to be diagnosed later. After surgery and any chemotherapy or radiation, daily life usually centers on several years of hormone therapy and regular follow-up visits with an exam and questions about new symptoms. Men who had a lumpectomy should have a yearly mammogram of the treated breast, and men with an inherited gene variant may also be offered yearly mammograms of the other breast. Breast MRI is not routinely needed. Hot flashes, sexual side effects and tiredness from tamoxifen can affect work, relationships and mood, and adjustments are sometimes possible. A positive genetic test adds another strand of planning: testing for relatives, and attention to the other cancers linked to the same gene. Much breast cancer information and many support services are designed around women, so it can help to ask the care team for resources and support groups that include men.
See a doctor about any new lump, thickening or change in the breast or nipple, nipple discharge, or a lump in the armpit, even when it is painless and even though most such changes turn out to be benign. Men with a known BRCA2 or other inherited variant, or with Klinefelter syndrome, should ask how often they need clinical breast exams. After treatment, tell the care team about a new lump in the chest wall, scar or armpit, new swelling in the arm on the treated side, or any new symptom that persists. While taking tamoxifen, call the care team right away about pain, redness or swelling in one calf, which can signal a blood clot. Sudden shortness of breath or chest pain while on tamoxifen needs emergency care (call 911), because a clot may have traveled to the lungs.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Male Breast Cancer is like, what's helped you, or ask the community a question.